Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio M Rodrigues

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Microbes and Infection|June 6, 2007
Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruziCarla Claser, Noeli Maria Espíndola, Gisela Sasso, et al.
Clinical and Vaccine Immunology : CVI|June 27, 2008
Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' diseaseEduardo L V Silveira, Carla Claser, Filipe A B Haolla, et al.
BMC Cell Biology|December 18, 2008
Silencing cytokeratin 18 gene inhibits intracellular replication of Trypanosoma cruzi in HeLa cells but not binding and invasion of trypanosomesCarla Claser, Marli Curcio, Samanta M de Mello, et al.
Anais Da Academia Brasileira De Ciencias|November 8, 2003
Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccinesMauricio M Rodrigues, Silvia B Boscardin, José R Vasconcelos, et al.
Human Gene Therapy|September 16, 2006
Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidaseAlexandre V Machado, Jarbas E Cardoso, Carla Claser, et al.
Clinical and Diagnostic Laboratory Immunology|September 11, 2003
Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatmentVera Lucia Pereira-Chioccola, Abilio Augusto Fragata-Filho, Antonio Marcos de Apparecida Levy, et al.
Microbes and Infection|August 12, 2008
Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infectionBruno C Múfalo, Fernanda Gentil, Daniel Y Bargieri, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 3, 2005
Polystyrene-type resin used for peptide synthesis: application for anion-exchange and affinity chromatographyRegina S H Carvalho, Danielle A Ianzer, Luciana Malavolta, et al.
Malaria Journal|November 18, 2003
Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1Maria Helena C Rodrigues, Maristela G Cunha, Ricardo LD Machado, et al.
Microbes and Infection|November 24, 2004
Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c miceNatalia Guiñazú, Andrea Pellegrini, Laura Giordanengo, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Microbes and Infection|June 6, 2007
Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruziCarla Claser, Noeli Maria Espíndola, Gisela Sasso, et al.
Clinical and Vaccine Immunology : CVI|June 27, 2008
Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' diseaseEduardo L V Silveira, Carla Claser, Filipe A B Haolla, et al.
BMC Cell Biology|December 18, 2008
Silencing cytokeratin 18 gene inhibits intracellular replication of Trypanosoma cruzi in HeLa cells but not binding and invasion of trypanosomesCarla Claser, Marli Curcio, Samanta M de Mello, et al.
Anais Da Academia Brasileira De Ciencias|November 8, 2003
Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccinesMauricio M Rodrigues, Silvia B Boscardin, José R Vasconcelos, et al.
Human Gene Therapy|September 16, 2006
Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidaseAlexandre V Machado, Jarbas E Cardoso, Carla Claser, et al.
Clinical and Diagnostic Laboratory Immunology|September 11, 2003
Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatmentVera Lucia Pereira-Chioccola, Abilio Augusto Fragata-Filho, Antonio Marcos de Apparecida Levy, et al.
Microbes and Infection|August 12, 2008
Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infectionBruno C Múfalo, Fernanda Gentil, Daniel Y Bargieri, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 3, 2005
Polystyrene-type resin used for peptide synthesis: application for anion-exchange and affinity chromatographyRegina S H Carvalho, Danielle A Ianzer, Luciana Malavolta, et al.
Malaria Journal|November 18, 2003
Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1Maria Helena C Rodrigues, Maristela G Cunha, Ricardo LD Machado, et al.
Microbes and Infection|November 24, 2004
Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c miceNatalia Guiñazú, Andrea Pellegrini, Laura Giordanengo, et al.
Pageof 7